BNGO Logo.png
Bionano Genomics Announces Pricing of $88.5 Million Underwritten Public Offering of Common Stock
January 08, 2021 08:45 ET | Bionano Genomics
SAN DIEGO, Jan. 08, 2021 (GLOBE NEWSWIRE) -- BIONANO GENOMICS, INC. (Nasdaq: BNGO), announced today the pricing of its previously announced underwritten public offering of 29,016,393 shares of its...
BNGO Logo.png
Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock
January 07, 2021 16:01 ET | Bionano Genomics
SAN DIEGO, Jan. 07, 2021 (GLOBE NEWSWIRE) -- BIONANO GENOMICS, INC. (Nasdaq: BNGO), announced today that it plans to offer and sell, subject to market and other conditions, shares of its common...
BNGO Logo.png
Bionano Genomics Publishes Study on Autism Risk Genes After Detailed Analysis of The Genome of Professor Temple Grandin, Who Has Brought Awareness to Autism Spectrum Disorder Through Her Activism
January 04, 2021 08:00 ET | Bionano Genomics
SAN DIEGO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today the publication in the Journal of Personalized Medicine by Lineagen, its CLIA certified diagnostic...
BNGO Logo.png
Bionano Genomics Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
December 30, 2020 08:00 ET | Bionano Genomics
SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Nasdaq has granted the Company an additional 180-day compliance period, or until June 28,...
BNGO Logo.png
Bionano Customer Praxis Genomics Accredited by College of American Pathologists, Completing First LDT in US for Constitutional Genetic Disorders that Uses Whole Genome Analysis with Saphyr as Alternative to Chromosomal Microarray and Karyotyping
December 28, 2020 08:00 ET | Bionano Genomics
SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Praxis Genomics, LLC received accreditation from the College of American Pathologists (CAP),...
BNGO Logo.png
Publication Reveals in Side-by-Side Comparison that Method Using PacBio Sequencing Detects Only 72% of the Large Structural Variants Detected by Optical Genome Mapping with Saphyr
December 23, 2020 08:00 ET | Bionano Genomics
SAN DIEGO, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study by the Human Genome Structural Variation Consortium (HGSVC) revealing that...
BNGO Logo.png
Bionano Genomics Achieves Key Milestone with Software Update for its Saphyr System that Increases Throughput to 96 Human Genomes Per Week and Adds Saphyr Assure for Monitoring System Health
December 21, 2020 08:00 ET | Bionano Genomics
Since its launch in 2017, Saphyr® throughput has increased by 1,400%, from a maximum of 384 human genomes per year to nearly 5,000 per year with the latest software release, representing the...
BNGO Logo.png
Bionano’s Saphyr System Used to Characterize Virus Integration Into Human Genome
December 15, 2020 08:00 ET | Bionano Genomics
SAN DIEGO, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a paper in the Proceedings of the National Academy of Sciences (PNAS) that describes...
BNGO Logo.png
Bionano Genomics Users Present the Saphyr System As a Novel Diagnostic Tool for Hematological Malignancies at ASH 2020
December 03, 2020 08:00 ET | Bionano Genomics
SAN DIEGO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its Saphyr System for optical genome mapping is being introduced as a novel diagnostic tool for heme...
BNGO Logo.png
Bionano Genomics and its Users Present the Saphyr System for Optical Genome Mapping and Various Advancements in Clinical Variant Detection at AMP 2020
November 19, 2020 08:00 ET | Bionano Genomics
SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that the performance and application of its Saphyr system for optical genome mapping are being showcased...